High BMI Increases Complications for Chest Masculinization Surgery

Follow Drugslib on

Medically reviewed by Drugs.com.

By Lori Solomon HealthDay Reporter

FRIDAY, Nov. 17, 2023 -- Among transgender and nonbinary patients undergoing chest masculinization surgery (CMS), people with high body mass index (BMI) have a slightly increased risk for complications, although the risk for serious complications is very low, according to a study published online Nov. 1 in the Annals of Plastic Surgery.

Bashar Hassan, M.D., from Johns Hopkins University in Baltimore, and colleagues examined the association between BMI and postoperative complications among transgender and nonbinary patients undergoing CMS. The analysis included 2,317 patients (median BMI was 27.4 kg/m2; range, 15.6 to 64.9 kg/m2).

The researchers found that while increasing BMI was significantly associated with greater odds of at least one complication, no patients experienced severe morbidity, regardless of BMI. Compared with patients without obesity, those with BMI ≥50 kg/m2 had tripled odds of at least one complication (adjusted odds ratio, 3.63) and 36.62-fold greater odds of urinary tract infection. Similarly, patients with BMI ≥35 kg/m2 had fivefold greater odds of readmission and surgical site infection compared with patients without obesity.

"Given the low risk for severe complications in higher BMI individuals, we recommend re-evaluation of BMI cutoffs for CMS patients," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2023-11-18 00:48

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords